REVB

Revelation Biosciences

• Dow Jones·1d ago

  *Revelation Biosciences Announces 1-for-7 Reverse Stock Split Effective October 20, 2026 >REVB

• TipRanks·08/19 21:29

  Revelation Biosciences Grants Performance-Based Executive Stock Awards

• TipRanks·08/07 18:25

  Revelation Biosciences (REVB) Gets a Buy from Roth MKM

• Seeking Alpha·08/07 13:38

  Revelation Biosciences GAAP EPS of -$0.87

• Seeking Alpha·08/03 13:45

  Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in July 2026

• TipRanks·08/03 13:15

  Revelation Biosciences announces results from market assessment for Gemini

• TipRanks·07/13 21:12

  Revelation Biosciences Adopts Stockholder Rights Protection Plan

• TipRanks·06/24 21:19

  Revelation Biosciences Updates Executive Contracts, Shareholder Actions

• TipRanks·06/01 13:56

  Revelation Biosciences adds two new members to AKI Advisory Board

• TipRanks·05/11 13:48

  Revelation Biosciences reports FY25 EPS ($14.35) vs ($1,052.16) last year

• TipRanks·05/08 17:31

  Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD), Enovis (ENOV) and Revelation Biosciences (REVB)

• Seeking Alpha·05/08 10:55

  Revelation Biosciences GAAP EPS of -$2.71

• TipRanks·04/06 13:18

  Revelation Biosciences announces formation of AKI advisory board

• TipRanks·03/30 19:56

  Revelation Gemini data show ‘broad effect,’ says Roth Capital

• TipRanks·03/30 13:21

  Revelation Biosciences presents additional data from Prime Clinical Study